News: LifeStream produziert neuen 3in1 Blutdruckmesser - 500 Beiträge pro Seite
eröffnet am 01.12.05 14:47:49 von
neuester Beitrag 13.12.05 17:45:05 von
neuester Beitrag 13.12.05 17:45:05 von
Beiträge: 69
ID: 1.023.781
ID: 1.023.781
Aufrufe heute: 0
Gesamt: 3.131
Gesamt: 3.131
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 37 Minuten | 7387 | |
vor 1 Stunde | 6649 | |
gestern 21:02 | 4998 | |
vor 32 Minuten | 4854 | |
gestern 21:55 | 4854 | |
vor 1 Stunde | 2797 | |
gestern 21:33 | 2599 | |
vor 21 Minuten | 2270 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.179,00 | +1,33 | 219 | |||
2. | 2. | 159,36 | +12,19 | 147 | |||
3. | 3. | 0,1910 | +4,95 | 81 | |||
4. | 4. | 2.322,19 | -0,19 | 60 | |||
5. | 5. | 0,0313 | +95,63 | 49 | |||
6. | 6. | 43,75 | -3,42 | 45 | |||
7. | 7. | 4,7480 | +3,15 | 43 | |||
8. | 8. | 14,475 | +5,46 | 41 |
Ganz aktuelle News von LifeStream.
Lifestream Technologies Signs Agreement With GenExel for New Three-in-One Unit
Thursday December 1, 6:30 am ET
Lifestream Sees a Bright Future for Innovative New Product
POST FALLS, Idaho--(BUSINESS WIRE)--Dec. 1, 2005--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream Three-In-One Blood Pressure monitor.
" We are pleased that, after over 6 months of review and discussions with numerous blood pressure manufacturers, GenExel met our stringent quality standards and had the clarity of vision for this market opportunity," stated Christopher Maus, Lifestream`s CEO. " This new technology will complement our product line and expand our present market opportunities in an area not yet commercialized."
The new Lifestream " Three-in-One" Blood Pressure monitor will measure blood pressure, cholesterol and HDL, all in less than three minutes. Consumer awareness for cholesterol testing can be significantly expanded through this merger. Between 5 to 7 million blood pressure monitors are sold each year in the U. S. or 14 million worldwide.
" The health conscious consumer, who uses or will use a blood pressure monitor, now has a real clear choice," continued Maus. " This dual use device supplies more meaningful information about a consumer`s cardiac health. The combined unit is also more cost effective and will play an essential role for individuals who are managing both blood pressure and cholesterol. There is an estimated 73% overlap of individuals with elevated blood pressure and high cholesterol. About 20 million people are on both blood pressure and cholesterol lowering medications."
" GenExel is pleased to be partnering with Lifestream on this very innovative product," said Dr. Douglas Stafford, Executive Vice President of GenExel. " Lifestream understands the market as much as GenExel does. This collaboration is perfect given that GenExel is also bringing an innovative Blood Pressure/Glucose monitor to the market. This product is a natural evolution for the hypertensive market. Together, Lifestream and GenExel have an opportunity to meet the goals of both companies and give health conscious consumers more quality choices."
Tolle Aussichten für LifeStream.
Neue Innovation am Markt zusammen mit GenExel.
Der Markt benötigt 20 Mio im Jahr.
Hier werden demnächst hohe Umsätze generiert!!
Lifestream Technologies Signs Agreement With GenExel for New Three-in-One Unit
Thursday December 1, 6:30 am ET
Lifestream Sees a Bright Future for Innovative New Product
POST FALLS, Idaho--(BUSINESS WIRE)--Dec. 1, 2005--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with GenExel-Sein, Inc., for the production of the new Lifestream Three-In-One Blood Pressure monitor.
" We are pleased that, after over 6 months of review and discussions with numerous blood pressure manufacturers, GenExel met our stringent quality standards and had the clarity of vision for this market opportunity," stated Christopher Maus, Lifestream`s CEO. " This new technology will complement our product line and expand our present market opportunities in an area not yet commercialized."
The new Lifestream " Three-in-One" Blood Pressure monitor will measure blood pressure, cholesterol and HDL, all in less than three minutes. Consumer awareness for cholesterol testing can be significantly expanded through this merger. Between 5 to 7 million blood pressure monitors are sold each year in the U. S. or 14 million worldwide.
" The health conscious consumer, who uses or will use a blood pressure monitor, now has a real clear choice," continued Maus. " This dual use device supplies more meaningful information about a consumer`s cardiac health. The combined unit is also more cost effective and will play an essential role for individuals who are managing both blood pressure and cholesterol. There is an estimated 73% overlap of individuals with elevated blood pressure and high cholesterol. About 20 million people are on both blood pressure and cholesterol lowering medications."
" GenExel is pleased to be partnering with Lifestream on this very innovative product," said Dr. Douglas Stafford, Executive Vice President of GenExel. " Lifestream understands the market as much as GenExel does. This collaboration is perfect given that GenExel is also bringing an innovative Blood Pressure/Glucose monitor to the market. This product is a natural evolution for the hypertensive market. Together, Lifestream and GenExel have an opportunity to meet the goals of both companies and give health conscious consumers more quality choices."
Tolle Aussichten für LifeStream.
Neue Innovation am Markt zusammen mit GenExel.
Der Markt benötigt 20 Mio im Jahr.
Hier werden demnächst hohe Umsätze generiert!!
Ihr müsst nichts dazu schreiben, genießt die News einfach.
Könnte der Durchbruch sein.
Mal sehen wie USA die News aufnimmt.
Könnte der Durchbruch sein.
Mal sehen wie USA die News aufnimmt.
da bin ich
Hi Börsen Loder
Neue News, Neuer Thread...
Ja also wenn das keine echt guten News sind dann weiß ich auch nicht... Dieser Wert hat echt unglaubliches potenzial!!!
Neue News, Neuer Thread...
Ja also wenn das keine echt guten News sind dann weiß ich auch nicht... Dieser Wert hat echt unglaubliches potenzial!!!
Ich denke auch dass wir der Durchbruch sein.
Aber es bleibt erstmal abzuwarten, wie USA die News bewertet, könnte natürlich gleich mehrere 100% geben, man weiss es nie.
Die letzten News waren schon super und jetzt das!!
Ich denke die nächsten Tage werden schöne.
Aber es bleibt erstmal abzuwarten, wie USA die News bewertet, könnte natürlich gleich mehrere 100% geben, man weiss es nie.
Die letzten News waren schon super und jetzt das!!
Ich denke die nächsten Tage werden schöne.
Gut das ich noch dabei geblieben bin
Das sind doch mal wieder sehr sehr gute News
Hoffe die Amis ziehen die Aktie jetzt endlich in die Regionen wo sie auch hingehört...
Berlin 0,01
Das sind doch mal wieder sehr sehr gute News
Hoffe die Amis ziehen die Aktie jetzt endlich in die Regionen wo sie auch hingehört...
Berlin 0,01
Da geht schon was!!
Also mit 0,0115 kann ich erstmal leben *G*
RT 0,0119
Kaufen und liegenlassen sag ich da nur...
Der Rest kommt von selbst!
Der Rest kommt von selbst!
Ich bin immer noch dabei ich muss nicht kaufen
RT 0,0125
RT 0,0125
Berlin jetzt RT 0,012
Der Ask steigt und steigt
Das wird noch richtig schön heut denke ich!!!
Das wird noch richtig schön heut denke ich!!!
ok!! RT 0,015
Die Bombe geht hoch
Die Bombe geht hoch
RT 0,016
0,015 x 0,016
0,015 x 0,016
Tja, jetzt gehts rund, hoffe ihr habt die Empfehlung angenommen!?
RT 0,018!!!!!!!!!!!!!!!!!!!!
100%
0,015 x 0,016
RT 0,016
RT 0,016
So ein Mist, hatte ganz vergessen meine Order für 0,009 zu löschen. und hab sie auch noch bekommen
Danke an meine Vergesslichkeit
Danke an meine Vergesslichkeit
RT 0,014 +55%
0,014 x 0,0145
0,014 x 0,0145
RT 0,0145
RT 0,0134
RT 0,0133
0,0133 x 0,0134
0,0133 x 0,0134
0,0145 bid
0,015 ask
0,015 ask
0,015 bid
0,0151 ask
0,0151 ask
0,0151 bid
0,016 ask
0,016 ask
0,0155 bid
0,016 ask
meine neue gfzx
0,016 ask
meine neue gfzx
In US RT 0,015
In Berlin stehen sich 0,015 auf der Kauf- und Verkaufsseite gegenüber... Ooh! Nur der Makler rafft es nicht.
Zum Thema GZFX, in meinem Orderbuch steht eine überteuerte Kauforder heute morgen von über 10 Mil! Ist das ein Fehler oder was?
In Berlin stehen sich 0,015 auf der Kauf- und Verkaufsseite gegenüber... Ooh! Nur der Makler rafft es nicht.
Zum Thema GZFX, in meinem Orderbuch steht eine überteuerte Kauforder heute morgen von über 10 Mil! Ist das ein Fehler oder was?
Ich beantworte mir die GZFX Frage selber. Stimmt nicht. In einem anderen Orderbuch wird die von mir geshene Order nicht geführt. War bestimmt nur ein Fehler...
Im Berliner OB steht
09:21:30 0,140 b 10.629.390 (GZFX)
In meinen anderen OB steht das nicht.
Berlin tickt heute nicht richtig....
LFTC RT 0,015 (0,0143 x 0,015)
Berlin 0,014 (0,013 x 0,014)
09:21:30 0,140 b 10.629.390 (GZFX)
In meinen anderen OB steht das nicht.
Berlin tickt heute nicht richtig....
LFTC RT 0,015 (0,0143 x 0,015)
Berlin 0,014 (0,013 x 0,014)
GZFX, dass war ein Tippfehler...
Lifestream ist auf derzeitiger Basis, mit diesen Fakten ein klarer Kauf!
Lifestream ist auf derzeitiger Basis, mit diesen Fakten ein klarer Kauf!
Auf den Boden der Realität zurück?
Was heisst das, auf den Boden der Realität zurück
Ich meinte den Kurs...
geht langsam wieder hoch
RT 0,0128
gerade vorher 0,0118...
geht langsam wieder hoch
RT 0,0128
gerade vorher 0,0118...
RT 0,0125
0,0121 x 0,0125
0,0121 x 0,0125
Es ist nur heftig zu sehen, dass Kauforders extrem über pari in Berlin stehen... Hoffentlich geht das gut!
RT 0,0125
0,012 x 0,0125
RT 0,0125
0,012 x 0,0125
Mal ganz im Ernst, meint Ihr das war es dann schon wieder
Können wir heute noch mal starten ????
Können wir heute noch mal starten ????
RT USA
war wohl nur ne kleine kerze........puuuuhhh hab grad noch zu 1,2 cent den abgang geschafft ........zu 0,6 cent kauf ich ne doppelte portion nochmal
RT 0,013
aber 0,0125 x 0,0128
aber 0,0125 x 0,0128
RT 0,012
Scheint nicht so gut im Ganzen rüber zu kommen die PR!
Am Anfang kamen die Zocker und dann setzte die Vernunft ein, Gewinne realisiert. Würde mich nicht wundern wenn´s weiter runter geht.
Schauen wir mal, hoffen wir mehr,
0,012 x 0,0125
Am Anfang kamen die Zocker und dann setzte die Vernunft ein, Gewinne realisiert. Würde mich nicht wundern wenn´s weiter runter geht.
Schauen wir mal, hoffen wir mehr,
0,012 x 0,0125
Gebt dem Jungen doch die 100000 zu 0,011, oder Mädchen
Ich wäre momentan vorsichtig, nach dem Debakel der letzten Wochen...
Halte trotzdem noch tapfer eine leichte Position zum Zocken..............................
Ich wäre momentan vorsichtig, nach dem Debakel der letzten Wochen...
Halte trotzdem noch tapfer eine leichte Position zum Zocken..............................
0,012 x 0,0124
Immer weiter runter!
SCHADE!!!!!!!!!!!!!!!
Hätte es gebrauchen können............
Immer weiter runter!
SCHADE!!!!!!!!!!!!!!!
Hätte es gebrauchen können............
Morgen ist ja auch noch ein Tag
Voll wie Ofen!!! Schwager war daaaaaaaaaaaaaaaaa
RT 0,0114 aber 0,0113 x 0,012
Wenn´s gut läuft, Prost, dann über 12
Börsen luuuuuuuuuuuuuuuder (loder),
lass mal wieder was hööööööören von Dir!
Prostataaaaaaaaaaaaaa!
RT 0,0114 aber 0,0113 x 0,012
Wenn´s gut läuft, Prost, dann über 12
Börsen luuuuuuuuuuuuuuuder (loder),
lass mal wieder was hööööööören von Dir!
Prostataaaaaaaaaaaaaa!
Bin schon da erik!
Schaut doch gut aus, warte mal die nächsten Tage ab, schönes Volumen.
Am Anfang hochgezockt und Gewinne mitgenommen, aber auch die Stücke die bei den Gewinnmitnahmen veräußert wurden hat ja irgendwer gekauft, und nicht ohne Grund, und diese Leute wollen auch ihre 100-300%, also wirds wohl weitergehen.
Nur meine Meinung.
GZFX wird die nächsten Tage wieder steil nach oben gehen...
Schaut doch gut aus, warte mal die nächsten Tage ab, schönes Volumen.
Am Anfang hochgezockt und Gewinne mitgenommen, aber auch die Stücke die bei den Gewinnmitnahmen veräußert wurden hat ja irgendwer gekauft, und nicht ohne Grund, und diese Leute wollen auch ihre 100-300%, also wirds wohl weitergehen.
Nur meine Meinung.
GZFX wird die nächsten Tage wieder steil nach oben gehen...
Mal sehen was es heute gibt.............
Erik
Erik
...den totalen Abgang!
RT 0,009
RT 0,009
Der 1-Tages-Zock ist vorbei !
[posting]19.138.077 von Csillagok am 02.12.05 17:54:26[/posting]unterschätze LFTC nicht...
sobald die Finanzierung steht... gehts gewaltig hoch
sobald die Finanzierung steht... gehts gewaltig hoch
[posting]19.139.346 von TB303 am 02.12.05 19:24:57[/posting]Sehe ich auch so. Und immer schön positiv bleiben!
Hallo!
Bin jetzt seit 0,01 drinn in lftc, Ihr schreibt von einer Finanzierung. Mein Frage was wird finanziert und wie, konnte nichts finden .Danke für Antwort.
Achso, heute schließen wir grün!
Grüße
Bin jetzt seit 0,01 drinn in lftc, Ihr schreibt von einer Finanzierung. Mein Frage was wird finanziert und wie, konnte nichts finden .Danke für Antwort.
Achso, heute schließen wir grün!
Grüße
Der Report scheint neu, aber wohl nicht so wichtig?
http://reports.finance.yahoo.com/w0?r=34975690:1
http://reports.finance.yahoo.com/w0?r=34975690:1
Lifestream Technologies Signs Agreement With Polymer for New Cholesterol/HDL Test
Tuesday December 13, 6:30 am ET
Lifestream to Bring a New Cholesterol/HDL Test to Market
POST FALLS, Idaho--(BUSINESS WIRE)--Dec. 13, 2005--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor.
"We are pleased that Lifestream and Polymer will collaborate to bring consumers the ability to measure not only total cholesterol but also HDL cholesterol," said Christopher Maus, Lifestream`s CEO. "Now, those who know both their total and HDL cholesterol can determine if they have a ratio that increases or decreases their risk for coronary heart disease. The addition of this important test will complement our present product and expand our market opportunities."
The supply relationship with Polymer meets the stringent quality standards required by Lifestream and provides the Company with a very competitive price. Requested by consumers and pharmacists alike, the HDL cholesterol test will give consumers an additional tool in monitoring their risk for heart disease. The Cholesterol:HDL ratio is a better indicator of the number one cause of death, heart disease, than cholesterol alone. Consumer awareness for cholesterol testing and heart disease can be significantly increased with the addition of this new chemistry.
"Polymer is pleased to be partnering with Lifestream on this project," stated Robert S. Huffstodt, Polymer`s CEO. "This agreement is beneficial for both companies, and expands the choices for the health conscious consumer. The ability to perform both tests with one analyzer is more cost effective for the consumer and allows them to monitor two risk factors important in preventing or managing heart disease."
About Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. (PTS), is a privately held, medical device company that has developed a family of proprietary products to rapidly and accurately test cholesterol and other lipids in the blood. Millions worldwide are at risk for cardiovascular disease -- the leading cause of death in the U.S. today -- and may not know it. Increasing awareness by regularly monitoring their levels may reinforce lifestyle changes and/or drug treatments designed to reduce their level of risk.
PTS` unique technology has led to the first and only FDA-cleared and CLIA-waived blood testing analyzer suitable for both the professional point of care testing market and the home testing market. The PTS system consists of the CardioChek(TM) family of instruments, and PTS PANELS(TM) Test Strips, which can test total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, as well as other analytes.
About Lifestream Technologies, Inc.
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides total cholesterol test results in three minutes.
The Company`s product aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s products also integrate a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval, trend analysis and assessment.
Lifestream`s monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream`s products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and in particular statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed January 12, 2005, and in "Item 1 - Business," "Item 6 - Management`s Discussion and Analysis or Plan of Operation," particularly the discussion under "Risk Factors - Substantial Doubt regarding our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2005, and the 10-QSB for the quarter ended September 30, 2005, all filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Forms 10-KSB and 10-QSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Contact:
Lifestream Technologies
Gerri Vance, 208-457-9409 ext. 1221
gerriv@lifestreamtech.com
or
Investor Relations
Equiti-trend LLC
Andy Arms
800-585-6988
858-436-3350 (local/international)
LFTC@equititrend.com
Source: Lifestream Technologies
Tuesday December 13, 6:30 am ET
Lifestream to Bring a New Cholesterol/HDL Test to Market
POST FALLS, Idaho--(BUSINESS WIRE)--Dec. 13, 2005--Lifestream Technologies, Inc. (OTCBB:LFTC - News), a leading supplier of cholesterol monitors, announced today that it has entered into an agreement with Polymer Technology Systems, Inc., for supply of test strips for its new Cholesterol/HDL monitor.
"We are pleased that Lifestream and Polymer will collaborate to bring consumers the ability to measure not only total cholesterol but also HDL cholesterol," said Christopher Maus, Lifestream`s CEO. "Now, those who know both their total and HDL cholesterol can determine if they have a ratio that increases or decreases their risk for coronary heart disease. The addition of this important test will complement our present product and expand our market opportunities."
The supply relationship with Polymer meets the stringent quality standards required by Lifestream and provides the Company with a very competitive price. Requested by consumers and pharmacists alike, the HDL cholesterol test will give consumers an additional tool in monitoring their risk for heart disease. The Cholesterol:HDL ratio is a better indicator of the number one cause of death, heart disease, than cholesterol alone. Consumer awareness for cholesterol testing and heart disease can be significantly increased with the addition of this new chemistry.
"Polymer is pleased to be partnering with Lifestream on this project," stated Robert S. Huffstodt, Polymer`s CEO. "This agreement is beneficial for both companies, and expands the choices for the health conscious consumer. The ability to perform both tests with one analyzer is more cost effective for the consumer and allows them to monitor two risk factors important in preventing or managing heart disease."
About Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. (PTS), is a privately held, medical device company that has developed a family of proprietary products to rapidly and accurately test cholesterol and other lipids in the blood. Millions worldwide are at risk for cardiovascular disease -- the leading cause of death in the U.S. today -- and may not know it. Increasing awareness by regularly monitoring their levels may reinforce lifestyle changes and/or drug treatments designed to reduce their level of risk.
PTS` unique technology has led to the first and only FDA-cleared and CLIA-waived blood testing analyzer suitable for both the professional point of care testing market and the home testing market. The PTS system consists of the CardioChek(TM) family of instruments, and PTS PANELS(TM) Test Strips, which can test total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, as well as other analytes.
About Lifestream Technologies, Inc.
The Company developed and currently markets a cholesterol monitor to consumers and healthcare professionals that provides total cholesterol test results in three minutes.
The Company`s product aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual`s efforts to improve compliance. Lifestream`s products also integrate a smart card reader further supporting compliance by storing test results on an individual`s personal health card for future retrieval, trend analysis and assessment.
Lifestream`s monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern(TM) Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream`s products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream`s products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties, and in particular statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results. The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed January 12, 2005, and in "Item 1 - Business," "Item 6 - Management`s Discussion and Analysis or Plan of Operation," particularly the discussion under "Risk Factors - Substantial Doubt regarding our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2005, and the 10-QSB for the quarter ended September 30, 2005, all filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Forms 10-KSB and 10-QSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Contact:
Lifestream Technologies
Gerri Vance, 208-457-9409 ext. 1221
gerriv@lifestreamtech.com
or
Investor Relations
Equiti-trend LLC
Andy Arms
800-585-6988
858-436-3350 (local/international)
LFTC@equititrend.com
Source: Lifestream Technologies
hier wird heute wird extrem angestiegen.
Leider ist es sehr schade, dass sich der Kurs nicht auf Dauer hoch halten kann, denn die Nachrichtenlage und somit die Fakten sprechen für Kurse um die 0,03€ oder mehr.
Es ist für mich nahezu unverständlich, dass die Aktie nach dem hoch bei 0,016$ sofort wieder runter auf den alten Stand gegangen ist.
Ich bin wieder dabei und glaube immer noch an das Modell.
Leider ist es sehr schade, dass sich der Kurs nicht auf Dauer hoch halten kann, denn die Nachrichtenlage und somit die Fakten sprechen für Kurse um die 0,03€ oder mehr.
Es ist für mich nahezu unverständlich, dass die Aktie nach dem hoch bei 0,016$ sofort wieder runter auf den alten Stand gegangen ist.
Ich bin wieder dabei und glaube immer noch an das Modell.
Kam soeben auf Stockhouse rein!!
Market Pulse Announces Its Hot Stock Alerts for Tuesday, Dec. 13, 2005: LFTC, QCOM, DYMTF, DELL
12/13/05
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued
by Market Pulse.
ATLANTA, GA, Dec 13, 2005 (MARKET WIRE via COMTEX) --
Market Pulse is pleased to introduce our featured stock, Lifestream Technologies, Inc. (OTC BB: LFTC), to the investment community! Lifestream is new to Market Pulse and is poised to become a significant player in the healthcare industry! LFTC just had excellent news out in a press release before today`s opening bell announcing that it has entered into an agreement with Polymer Technology Systems, Inc. for supply of test strips for its new Cholesterol/HDL monitor! This could be great news for investors! Other notable stocks that should be watched because they look great lately from a fundamental and technical perspective include:
Qualcomm Inc. (NASDAQ: QCOM) : Market Outperform
DynaMotive Energy Systems Corp. (OTC BB: DYMTF) : Attractive
Dell Inc. (NASDAQ: DELL) : Market Underperform
Recommendation Meanings
These recommendations are investment opinions of Market-Pulse.com and reflect the stock`s potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.
Market Pulse Announces Its Hot Stock Alerts for Tuesday, Dec. 13, 2005: LFTC, QCOM, DYMTF, DELL
12/13/05
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued
by Market Pulse.
ATLANTA, GA, Dec 13, 2005 (MARKET WIRE via COMTEX) --
Market Pulse is pleased to introduce our featured stock, Lifestream Technologies, Inc. (OTC BB: LFTC), to the investment community! Lifestream is new to Market Pulse and is poised to become a significant player in the healthcare industry! LFTC just had excellent news out in a press release before today`s opening bell announcing that it has entered into an agreement with Polymer Technology Systems, Inc. for supply of test strips for its new Cholesterol/HDL monitor! This could be great news for investors! Other notable stocks that should be watched because they look great lately from a fundamental and technical perspective include:
Qualcomm Inc. (NASDAQ: QCOM) : Market Outperform
DynaMotive Energy Systems Corp. (OTC BB: DYMTF) : Attractive
Dell Inc. (NASDAQ: DELL) : Market Underperform
Recommendation Meanings
These recommendations are investment opinions of Market-Pulse.com and reflect the stock`s potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.
RT 0,011
+ 44,73 %
+ 44,73 %
RT 0,0129
+ 69,73 %
+ 69,73 %
Was begründet diesen Anstieg?
Habe die News gesehen, aber mein Englisch läßt zu wünschen übrig. KAnn jemand helfen?
Danke
Habe die News gesehen, aber mein Englisch läßt zu wünschen übrig. KAnn jemand helfen?
Danke
RT 0,0137
Warum????
Warum????
Gleich haben wir die 100% voll
Aber warum, weiß auch du nicht , oder?
[posting]19.275.686 von Deggen am 13.12.05 17:12:47[/posting]@Deggen,
was ist los. Postest ständig Kurse und hast genau so wenig Ahnung wie ich. Klasse, wie man sich hier austauscht.
was ist los. Postest ständig Kurse und hast genau so wenig Ahnung wie ich. Klasse, wie man sich hier austauscht.
[posting]19.275.686 von Deggen am 13.12.05 17:12:47[/posting]0,012 , oder bist du nur für
aufsteigende Kurse zuständig.
MFG
aufsteigende Kurse zuständig.
MFG
Jetzt bleib mal geschmeidig
In den News steht, dass sie einen Vertag mit Polymer über neue Teststreifen für ihre Cholesterin HDLMonitore abgeschlossen haben.
"Unsere Kunden haben jetzt die Möglichkeit nicht nur die Cholesterinwerte sondern auch ihre HDL-Cholesterinwerte zu messen. Das Hinzufügen dieses wichtigen Testes wird unser jetziges Produkt vervollständigen und unsere Chancen auf dem Markt erweitern."
RT 0,013
Ich hoffe wir können dieses Niveau bis heute Abend halten, denn dann könnte es so laufen wie bei der letzten Lizensvereinbarung mit LifeNexus...
In den News steht, dass sie einen Vertag mit Polymer über neue Teststreifen für ihre Cholesterin HDLMonitore abgeschlossen haben.
"Unsere Kunden haben jetzt die Möglichkeit nicht nur die Cholesterinwerte sondern auch ihre HDL-Cholesterinwerte zu messen. Das Hinzufügen dieses wichtigen Testes wird unser jetziges Produkt vervollständigen und unsere Chancen auf dem Markt erweitern."
RT 0,013
Ich hoffe wir können dieses Niveau bis heute Abend halten, denn dann könnte es so laufen wie bei der letzten Lizensvereinbarung mit LifeNexus...
[posting]19.276.134 von Deggen am 13.12.05 17:40:23[/posting]Danke Dir und nicht böse sein. Wollte dich nur Locken, damit ich mal eine Antwort bekomme.
Du scheinst ja momentan der Einzige zu sein, der hier die Fahne hoch hält.
Also, nicht übel nehmen.
MFG
Du scheinst ja momentan der Einzige zu sein, der hier die Fahne hoch hält.
Also, nicht übel nehmen.
MFG
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
219 | ||
147 | ||
81 | ||
60 | ||
49 | ||
45 | ||
43 | ||
41 | ||
37 | ||
30 |
Wertpapier | Beiträge | |
---|---|---|
26 | ||
23 | ||
22 | ||
21 | ||
21 | ||
21 | ||
20 | ||
20 | ||
19 | ||
19 |